We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$75.7B
AUM Growth
+$6.94B
Cap. Flow
-$695M
Cap. Flow %
-0.92%
Top 10 Hldgs %
38.84%
Holding
852
New
205
Increased
261
Reduced
298
Closed
58

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$840M
2
DIS icon
Walt Disney
DIS
+$492M
3
BA icon
Boeing
BA
+$492M
4
SBUX icon
Starbucks
SBUX
+$276M
5
SLB icon
SLB Ltd
SLB
+$216M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Consumer Discretionary 16.31%
3 Communication Services 13.43%
4 Healthcare 12.88%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
401
Lantheus
LNTH
$6.59B
$5.65M 0.01%
418,567
+115,279
+38% +$1.51M
BWXT icon
402
BWX Technologies
BWXT
$15.7B
$5.63M 0.01%
93,408
-6,195
-6% -$357K
LILAK icon
403
Liberty Latin America Class C
LILAK
$1.67B
$5.3M 0.01%
526,163
-13,815
-3% -$136K
DK icon
404
Delek US
DK
$3.77B
$5.16M 0.01%
320,970
-10,716
-3% -$141K
NX icon
405
Quanex
NX
$998M
$4.99M 0.01%
+225,004
New +$4.63M
ALTG icon
406
Alta Equipment Group
ALTG
$246M
$4.91M 0.01%
496,869
-16,574
-3% -$143K
ATKR icon
407
Atkore
ATKR
$3.17B
$4.89M 0.01%
+118,982
New +$3.75M
KE
408
Kimball Electronics
KE
$621M
$4.84M 0.01%
302,582
-9,529
-3% -$135K
CVS icon
409
CVS Health
CVS
$120B
$4.71M 0.01%
68,937
+51,302
+291% +$3.34M
KLAC icon
410
KLA
KLAC
$265B
$4.65M 0.01%
179,620
+64,350
+56% +$1.5M
AZZ icon
411
AZZ Inc
AZZ
$4.67B
$4.48M 0.01%
+94,449
New +$3.82M
VNET
412
VNET Group
VNET
$2.14B
$3.75M 0.01%
108,188
+22,851
+27% +$600K
NXDT
413
NexPoint Diversified Real Estate Trust
NXDT
$245M
$3.58M ﹤0.01%
340,284
UTMD icon
414
Utah Medical Products
UTMD
$229M
$3.57M ﹤0.01%
42,377
-838
-2% -$71.4K
IWF icon
415
iShares Russell 1000 Growth ETF
IWF
$128B
$3.47M ﹤0.01%
57,520
+49,876
+652% +$2.84M
QDEL icon
416
QuidelOrtho
QDEL
$918M
$3.43M ﹤0.01%
19,112
-18,297
-49% -$4.07M
GDS icon
417
GDS Holdings
GDS
$6.41B
$3.33M ﹤0.01%
35,531
+9,217
+35% +$819K
VTA
418
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$3.13M ﹤0.01%
291,620
+6,702
+2% +$66.1K
DESP
419
DELISTED
Despegar.com
DESP
$3.03M ﹤0.01%
236,625
+104,862
+80% +$1.01M
BATL icon
420
Battalion Oil
BATL
$30.2M
$3M ﹤0.01%
361,387
-3,219
-0.9% -$24.2K
VUG icon
421
Vanguard Morningstar Growth ETF
VUG
$230B
$2.76M ﹤0.01%
65,418
+57,354
+711% +$2.29M
MCD icon
422
McDonald's
MCD
$193B
$2.56M ﹤0.01%
11,919
+1,671
+16% +$363K
BKNG icon
423
Booking.com
BKNG
$160B
$2.55M ﹤0.01%
28,575
+1,975
+7% +$152K
CRC icon
424
California Resources
CRC
$4.87B
$2.44M ﹤0.01%
+103,329
New +$1.9M
VVR icon
425
Invesco Senior Income Trust
VVR
$459M
$2.24M ﹤0.01%
562,129
+9,167
+2% +$34.5K

Similar funds

Loomis, Sayles & Company's Q4 2020 Portfolio in Review

As of Q4 2020, Loomis, Sayles & Company held 852 positions worth $75.7B, up 10% from $68.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q4 2020 filing shows 205 new, 261 increased, 298 reduced and 58 closed positions. Its largest new stake was TSMC: 1,053,323 shares worth $115M. The largest sale was Varian Medical Systems, Inc., an estimated $442M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2020 buy was TSMC: 1,053,323 shares worth $115M.
  • Loomis, Sayles & Company added most to Novartis in Q4 2020, an estimated $840M increase.
  • Loomis, Sayles & Company's biggest Q4 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $442M.
  • Loomis, Sayles & Company fully exited Palomar in Q4 2020, selling an estimated $64.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $75.7B portfolio in Q4 2020.
  • Loomis, Sayles & Company opened 205 new positions and closed 58 in Q4 2020.
  • Loomis, Sayles & Company's portfolio value rose 10% quarter-over-quarter to $75.7B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2020, filed 12 Feb 2021.